Registration - Amendment

ASTELLAS PHARMA US, INC. for ASTELLAS PHARMA US, INC.

Firm
Client
Income
—
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Issues and bills related to and affecting the pharmaceutical industry, including those most recently disclosed on the 2018 April Quarterly Report (i.e. Medicare Part D, Bayh-Dole Act, IRC Section 385, H.R.4170, S. 2482, etc.).

LobbyistCovered position, as disclosed
JOSEPH DEVANEY New —
VALARIE MOLAISON New —
MARY LACEY REUTHER New —

Bills named: S. 2482 (115th), H.R. 4170 (115th)

Health Issues HCR

Issues and bills related to and affecting the pharmaceutical industry, including those most recently disclosed on the 2018 April Quarterly Report (i.e. Medicare Part D, Bayh-Dole Act, IRC Section 385, H.R.4170, S. 2482, etc.).

LobbyistCovered position, as disclosed
JOSEPH DEVANEY New —
VALARIE MOLAISON New —
MARY LACEY REUTHER New —

Bills named: S. 2482 (115th), H.R. 4170 (115th)

Medicare/Medicaid MMM

Issues and bills related to and affecting the pharmaceutical industry, including those most recently disclosed on the 2018 April Quarterly Report (i.e. Medicare Part D, Bayh-Dole Act, IRC Section 385, H.R.4170, S. 2482, etc.).

LobbyistCovered position, as disclosed
JOSEPH DEVANEY New —
VALARIE MOLAISON New —
MARY LACEY REUTHER New —

Bills named: S. 2482 (115th), H.R. 4170 (115th)

Law Enforcement/Crime/Criminal Justice LAW

Issues and bills related to and affecting the pharmaceutical industry, including those most recently disclosed on the 2018 April Quarterly Report (i.e. Medicare Part D, Bayh-Dole Act, IRC Section 385, H.R.4170, S. 2482, etc.).

LobbyistCovered position, as disclosed
JOSEPH DEVANEY New —
VALARIE MOLAISON New —
MARY LACEY REUTHER New —

Bills named: S. 2482 (115th), H.R. 4170 (115th)

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
ASTELLAS PHARMA, INC. Japan Japan 99.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.